This study presented the fabrication of macro and micro-scale microbial fuel cells (MFCs) to generate bioelectricity from oxalate solution and monitor the biodegradation in a micro-scale MFC for the first time. The maximum generated power density of 44.16 W m−3 in the micro-scale MFC elucidated its application as a micro-sized power generator for implantable medical devices (IMDs). It is also worthwhile noting that for the macro-scale MFC, the significant amounts of open circuit voltage, oxalate removal, and coulombic efficiency were about 935 mV, 99%, and 44.2%, respectively. These values compared to previously published studies indicate successful oxalate biodegradation in the macro-scale MFC. Regarding critical challenges to determine the substrate concentration in microfluidic outlets, sample collection in a suitable time and online data reporting, an analogy was made between macro and micro-scale MFCs to elicit correlations defining the output current density as the inlet and the outlet oxalate concentration. Another use of the system as an IMD is to be a platform to identify urolithiasis and hyperoxaluria diseases. As a versatile device for power generation and oxalate biodegradation monitoring, the use of facile and cheap materials (< $1.5 per device) and utilization of human excreta are exceptional features of the manufactured micro-scale MFC.
25 January 2023 in Journal of Environmental Chemical Engineering
This study conducted in vitro experimentation using microvascular tissue-like structures to examine the dynamics of interfacial forces leading to gas bubble cessation, with the objective of providing a medical guideline for preventing gas embolism.
Gas embolism is a medical condition leading to the blockage of blood flow in the microvasculature by gas bubbles. While reported as rare, gas embolism often has devastating, fatal physiological consequences. Despite this acute importance, the genesis and evolution of air bubbles in blood vessels under different physiological conditions, such as blood viscosity and blood flow rate, is still understudied, largely because of difficult experimentation and in situ visualization. The objective of this work was to study the gas embolism phenomenon in vitro, using a microfluidic system that mimicked the architecture of microvasculature. The microfluidic systems comprised linear channels with two different air inlet types, namely, T- and Y-junctions with three different widths (20 µm, 40 µm, and 60 µm), and a 30 µm width honeycombed network with three bifurcation angles (30°, 60°, and 90°). Three synthetic liquids equivalent to 0%, 20%, and 46% hematocrit that mimicked the physiological blood viscosity and hematocrit concentrations were used. Our results show that: (i) 20 µm and 40 µm width channels had an elevated risk of gas embolism due to wide fluctuations in the total slug sizes; (ii) the resistance to the flow of air bubbles increased with the increase in the equivalent concentration of hematocrit; (iii) gas bubbles causing blockages and dampening of the flow velocity were frequently observed in 20 µm channels, and lastly (iv) increased risk of gas embolism was observed in the honeycomb architecture with 60° and 30° bifurcations. This work suggests that in vitro experimentation using microfluidic devices with microvascular tissue-like structures opens the possibility of studying this medical condition with high reproducibility and impacts the fact-based medical guidelines for preventing or mitigating iatrogenic occurrences.